Small Molecules
6 March 2018
Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis6 March 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation5 March 2018
The European Medicines Agency accepts regulatory submission for Forxiga in adults with type-1 diabetes5 March 2018
Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH2 March 2018
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients1 March 2018
Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola28 February 2018
Celgene Provides Regulatory Update on Ozanimod for the Treatment of Relapsing Multiple Sclerosis28 February 2018
Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients27 February 2018
Lilly Receives Additional FDA Approval for Verzenio™ (abemaciclib), as Initial Treatment for Advanced Breast Cancer27 February 2018
Daiichi Sankyo Announces NDA submission in Japan of Esaxerenone for Treatment of HypertensionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports